Immiticide 50 mg Powder For Solution is a Health Canada–registered veterinary drug (DIN 02242073) held by Boehringer Ingelheim Animal Health Canada Inc., containing Melarsomine Dihydrochloride. Health Canada lists its status as Marketed (status date 27 Nov 2019). Nexara Health has matched 3 registrations of Melarsomine Dihydrochloride across 2 other regulated markets.
Health Canada registration
| DIN | 02242073 |
|---|---|
| Brand name | Immiticide |
| Active ingredient | Melarsomine Dihydrochloride |
| Strength | 50 mg |
| Dosage form | Powder For Solution |
| Route | Intramuscular |
| Company | Boehringer Ingelheim Animal Health Canada Inc. |
| Status | Marketed — 27 Nov 2019 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Melarsomine Dihydrochloride registered in other markets
3 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | Immiticide Freeze Dried Powder for Injection 50mg | Rhone Ma Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| United States | Melarsomine Dihydrochloride | Sentio BioSciences LLC | Powder | FDA NDC | ||
| United States | Melarsomine Dihydrochloride | Loba biotech GmbH | Powder | FDA NDC |
See every manufacturer of Melarsomine Dihydrochloride worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Immiticide (DIN 02242073) marketed in Canada?
Yes. Health Canada lists DIN 02242073 as Marketed as of 27 Nov 2019.
Who holds the Canadian licence for this product?
Boehringer Ingelheim Animal Health Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Melarsomine Dihydrochloride registered outside Canada?
Yes — Nexara Health has matched 3 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02242073, status date 2019-11-27; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02242073, status date 2019-11-27; national medicine registries: FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 02242073, status date 2019-11-27; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.